Gedeon Richter launches operations in Colombia
Gedeon Richter lanza operaciones en Colombia
Intel ID : 239198
| Synopsis |
|
Gedeon Richter (FWB:RIG2), a Budapest, Hungary-based pharmaceutical company, continues its expansion in Latin America with the launch of operations in Colombia, reported Portafolio on 28 July 2016. Specifically, in Colombia, the company will offer innovative therapeutic alternatives for doctors and patients in the treatment of diseases that affect women. Globally, Gedeon Richter manufactures drugs in Germany, Switzerland, Poland, Russia, India, Romania, and China. In Latin America, it is present in Mexico.
(content in spanish)
Gedeon Richter (FWB:RIG2), farmacéutica con sede en Budapest, Hungría, continua su expansión por Latinoamérica con el lanzamiento de operaciones en Colombia, ha publicado Portafolio el 28 de julio de 2016. En concreto, en Colombia la empresa ofrecerá alternativas terapéuticas innovadoras para médicos y pacientes en el tratamiento de enfermedades que afectan a las mujeres. A nivel mundial, Gedeon Richter produce medicamentos en Alemania, Suiza, Polonia, Rusia, India, Rumania y China. En Latinoamérica, tiene presencia en México. |
| Intel ID | 239198 | |
| Value | ND | |
| Native Currency |
US Dollar (USD)
Exchange Rate: |
|
| Date |
|
|
| Country | ![]() |
|
| Region | ||
| Continent | ![]() |
|
| Geography | ![]() |
|
| Subsector (Old TTR Sectors) |
|
|
| Type |
|
|
| Intel Grade |
|
|
| Source |
|
|
| Tags | ![]() |
Bidder
| Name |
|
||
| Subsector (Old TTR Sectors) |
|
||
| Primary Sector (TTRSC) |
30.01.03 Pharmaceutical R&D, Manufacturing & Distribution 30 Healthcare / 30.01 Biotechnology & Pharmaceuticals |
||
| Secondary Sectors (TTRSC) |
15.04.03 Personal Care Products 15 Consumer Products & Services / 15.04 Consumer Nondurables |
||
| Country |
|
||
| Website |
|
||
| Description |
|
Legend:
Verified: Confirmed as a party to an active or possible transaction.
Potential: Unconfirmed as a party to an active or possible transaction.
Retained: Confirmed as “Retained” with a general or specific mandate.
Prospect: Advisory “Prospect” in discussions with or pitching services to possible client.
Transactional data is continuously updated by the research team and therefore is subject to change.
